Maximum tolerated dose

BIOLOGICAL2 trials

Sponsors

Medical College of Wisconsin, Institute of Cancer Research, United Kingdom

Conditions

High Grade Serous Ovarian CancerMultiple Myeloma

Phase 1

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Not yet recruitingNCT05976555

Medical College of WisconsinMultiple Myeloma

Start: 2026-03-01End: 2029-05-31Target: 30Updated: 2025-06-11

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

RecruitingNCT06976892

Institute of Cancer Research, United KingdomHigh Grade Serous Ovarian Cancer

Start: 2025-08-31End: 2029-12-31Target: 33Updated: 2025-08-13